SHULMAN JOHN D 13D and 13G filings for Petros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-28 4:30 pm Purchase |
2021-12-02 | 13D | Petros Pharmaceuticals, Inc. PTPI |
SHULMAN JOHN D | 788,093 34.470% |
113,635 (+16.85%) |
Filing |
| 2021-10-20 5:25 pm Purchase |
2021-10-18 | 13D | Petros Pharmaceuticals, Inc. PTPI |
SHULMAN JOHN D | 674,458 51.190% |
334,861 (+98.61%) |
Filing |
| 2020-12-11 5:26 pm Purchase |
2020-12-01 | 13D | Petros Pharmaceuticals, Inc. PTPI |
SHULMAN JOHN D | 339,596 34.900% |
339,596 (New Position) |
Filing |